ftInvstr
SAIPARENT · Healthcare ₹507.5 +5.04% Mkt Cap ₹2245 Cr undervalued
← Search another stock

SAIPARENT

Healthcare Drug Manufacturers - General
★ Watchlist ⧉ Add to bucket
₹507.5
+5.04% today · 30d +2.53%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SAIPARENT. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹195 Cr
NET PROFIT
₹11 Cr
OPM
22.13%
EPS
₹2.38
PE 89.71
Intrinsic value · DCF ₹840.41 · Margin of safety +65.6% (undervalued) · FCF yield 3.33%
◇ Sector Position
PEERPEROCE %
SAIPARENT89.71—
GLAXO40.0557.97
RUBICON90.2127.36
PFIZER20.9324.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
58
SCORE / 100
Overall
6-axis composite of the sections below.
Performance — —
Valuation STRETCHED 20
Growth STEADY 59
Profitability HIGH 75
Technicals WEAK 47
Risk LOW 90
Key Stats
TTM PE
89.71
P/B
4.51
52W HIGH
₹706.0
OFF HIGH
-28.12%
DIV YIELD
0.0%
MKT CAP
₹2245 Cr
◉ Active Signals
MACDNeutral3.123
RSI(14)Neutral55.15
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SAIPARENT and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.